Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284280 · ClinicalTrials.gov registry record · NA
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
A NA study of Necrotizing Enterocolitis and Poor Growth in Extremely Preterm Infants, sponsored by Crouse Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04284280 is a NA study of Necrotizing Enterocolitis and Poor Growth in Extremely Preterm Infants that is actively recruiting participants, run by Crouse Hospital. The registered enrollment target is 200 participants, below the 299-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04284280, a NA study of Necrotizing Enterocolitis and Poor Growth in Extremely Preterm Infants, is actively recruiting participants, sponsored by Crouse Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Routine vs Selective use of Human Milk Donor Fortifier
Study Locations (1)
New York
- Crouse Hospital - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-02-15 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04284280
The ClinicalTrials.gov registry entry for NCT04284280 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 299-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (33% lower). The listed sponsor is Crouse Hospital, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Necrotizing Enterocolitis appearing as the primary indexed condition, and to 1 intervention - of which Routine vs Selective use of Human Milk Donor Fortifier is the first listed.
NCT04284280 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04284280 about?
NCT04284280 is a clinical study titled "Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants". The aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.
What is the current status of trial NCT04284280?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2020-02-15. Estimated completion is 2027-02-01.
What conditions does trial NCT04284280 study?
This clinical trial studies the following conditions: Necrotizing Enterocolitis, Poor Growth in Extremely Preterm Infants.
What interventions are being tested in trial NCT04284280?
The interventions under investigation include: Routine vs Selective use of Human Milk Donor Fortifier (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04284280?
This trial is sponsored by Crouse Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04284280 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Necrotizing Enterocolitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collaborative Research Group for Necrotizing Enterocolitis
COMPLETED · NA
-
Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants
COMPLETED · NA
-
Early Predictors of Necrotizing Enterocolitis in Neonates
RECRUITING
-
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
RECRUITING · Phase 1
-
A Cohort Study of the Intestinal Microbiota of Premature Infants
ACTIVE NOT RECRUITING
-
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
ACTIVE NOT RECRUITING · Phase 3
Explore more on PlainTrial
Necrotizing Enterocolitis
All registered trials for this condition
Poor Growth in Extremely Preterm Infants
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.